BioCentury
ARTICLE | Company News

Management tracks

March 12, 2015 1:42 AM UTC

Neovacs S.A. (Euronext:ALNEV) hired Therese Croughs as CMO, effective immediately, and promoted Geraldine Grouard-Vogel to CSO from head of research and preclinical development. Croughs, who succeeds Pierre Vandepapeliere, was CMO at Cytheris S.A. (Issy-les-Moulineaux, France).

The U.K.'s Department of Health said Hugh Taylor will lead its Innovative Medicines and Medical Technology Review and John Bell will head an expert advisory group to support the review. Taylor is chair of Guy's and St. Thomas' NHS Foundation Trust. Bell is a Regius professor of medicine at the University of Oxford. ...